Mariia Moshkova

Mariia Moshkova

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
EGElizaveta Gusarova
Elizaveta Gusarova
FAFatemeh Ahmadi
Fatemeh Ahmadi
JCJennifer Cruickshank
Jennifer Cruickshank
ZMZheyuan Miao
Zheyuan Miao
MMMariia Moshkova
Mariia Moshkova
EKEugenia Kumacheva
Eugenia Kumacheva
Patient‐derived cancer organoids have emerged as a promising in vitro model for fundamental cancer research and drug screening for therapeutic cancer treatment. Yet, while the inherent acidification of the tumor environment in vivo is controlled at a particular level, hydrogel scaffolds used for organoid culture lack this ability and their pH falls outside the physiologically relevant range. The excessive acidification can also lead to the degradation of pH‐sensitive hydrogel scaffolds during long‐term organoid culture, thus changing the mechanical properties of the organoid microenvironment. Here, we report a biomimetic fibrous hydrogel with built‐in buffering capacity, which enables control of the local acidification of the organoid environment to maintain its mechanical and structural stability. The hydrogel is formed from aldehyde‐functionalized cellulose nanocrystals carrying histidine buffering molecules, and gelatin. During long‐term organoid culture, the hydrogel maintained the pH in the physiologically relevant range, while maintaining network integrity and mechanical properties. The organoids grown in this hydrogel exhibited enhanced proliferative activity of cancer cells, thus reflecting a more homeostatic tumor‐like niche. This work shows that introducing a buffering functionality into the hydrogel scaffold enables significantly improved support for long‐term culture of patient‐derived breast cancer organoids under physiologically relevant conditions.

28 December 2024 in Morphology
Verified
Journal Article
Open access
PDF file
ISIrina Sorochanu
Irina Sorochanu
KBKristina S. Blitzine
Kristina S. Blitzine
DDDauddin I. Daudi
Dauddin I. Daudi
NZNikita I. Zhemkov
Nikita I. Zhemkov
APAlina A. Pechenina
Alina A. Pechenina
RDRoman Deev
Roman Deev
BACKGROUND: Impaired reparative regeneration leads to insufficient extracellular matrix formation and the development of chronic wounds, necessitating a personalized therapeutic approach. In modern regenerative medicine, biopolymers such as silk proteins serve as the basis for wound dressings and drug delivery systems due to their unique properties. The biocompatibility, modulation of intracellular signaling pathways, and antibacterial activity of spidroin (spider silk protein), fibroin, and sericin (silkworm silk proteins) suggest their potential for wound healing applications. AIM: To evaluate the effects of a spidroin, fibroin, and sericin-based cream on skin regeneration in rats. METHODS: The study included 30 male rats, in which full-thickness excisional skin defects (20 mm in diameter) were created on the back. The animals were divided into three groups: the experimental group, which received daily applications of the test cream, and two control groups—one treated with 5% dexpanthenol and the other left to undergo natural wound healing. Planimetric and histomorphometric analyses, along with clinical blood tests, were performed to assess reparative regeneration and systemic reactive changes. RESULTS: The application of the test cream significantly accelerated wound healing, with complete skin restoration in the experimental group by day 14 compared to the untreated control group. Analysis of inflammatory activity showed moderate granulocytosis and signs of acute posthemorrhagic anemia without pronounced inflammatory alterations in blood parameters. Additionally, immune cell infiltration was lower in the experimental group than in the controls. CONCLUSION: The combination of spider silk proteins (spidroin) and silkworm silk proteins (fibroin and sericin) enhances cell migration, proliferation, and differentiation, promotes extracellular matrix formation, and exerts anti-inflammatory effects without immunogenic properties. These findings support the potential clinical use of this silk protein-based formulation as a therapeutic agent for treating wounds with pathological regeneration.